Franco Valle, Senior Vice President, Finance at Eidos Therapeutics, Inc. (EIDX), sold 5,000 shares at $48.85 ($241K) on 2020-03-26, disclosed to the SEC on 2020-03-30.
Open-market sale of $241k EIDX by Senior Vice President, Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.87 | 3,000 | $144K | 59.5% |
| 2 | $48.85 | 2,000 | $98K | 40.5% |
| Total | $48.26 avg | 5,000 | $241K | 100% |
| Filing → |
| BMEA | BUY | 2022-01-18 | $87K | — | Filing → |
| EIDX | SELL | 2021-01-13 | $627K | — | Filing → |
| EIDX | SELL | 2020-11-10 | $243K | — | Filing → |